|Articles|September 1, 2007

VTE RISK REDUCED WITH LONGER DURATION OF PROPHYLAXIS

Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.

A recent studyof nonsurgical patientssuggests thatextending venousthromboembolism(VTE) prophylaxisfor 1 month postdischargecan lowerVTE risk by 44%. The study, whichwas conducted in Europe and NorthAmerica, randomized acutely illpatients who were immobilized in thehospital to either stop VTE prophylaxisat discharge or continue it at home for1 month. This is the first study to lookat extending prophylaxis beyond 7 to10 days post-discharge in medicalpatients. The reduction in VTE eventsextended out to 90 days. Bleedingevents were higher in the extendedprophylaxisgroup, but the authors concludedthat bleeding events were inline with expectations and did notappear clinically significant.

The results of this study are importantbecause sicker patients are beingdischarged from the hospital. Their riskof VTE after discharge may increasebecause there may be less encouragementgiven to the patient by caregiversto maintain mobility. Extended VTE prophylaxisappears to lessen this risk.

Articles in this issue

about 18 years ago

Article

Calming the Symptoms of Menopause

about 18 years ago

Article

Zoster Vaccine

about 18 years ago

Article

pharmacy TECHNOLOGY products

about 18 years ago

Article

health-systems PRODUCT news

about 18 years ago

Article

can you READ these Rxs?

about 18 years ago

Article

can you READ these Rxs?

about 18 years ago

Article

Generic Times Product News

about 18 years ago

Article

compounding HOTLINE

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME